Company Filing History:
Years Active: 2002
Title: Bo Kreilgaard: Innovator in Transdermal Drug Delivery
Introduction
Bo Kreilgaard is a notable inventor based in Hilleröd, Denmark. He has made significant contributions to the field of pharmaceuticals, particularly in the area of transdermal drug delivery systems. His innovative work has led to the development of a unique method for administering medications effectively.
Latest Patents
Kreilgaard holds a patent for a device that facilitates the transdermal administration of dextromethorphan, a compound known for its antitussive properties. The patent, titled "Transdermally administered dextromethorphan as antitussive agent," outlines a method for delivering this medication through the skin, utilizing a pharmaceutically acceptable carrier. This invention aims to provide relief from cough in both humans and animals.
Career Highlights
Throughout his career, Bo Kreilgaard has been associated with Pharmacia & Upjohn Ab, where he has contributed to various research and development projects. His expertise in drug formulation and delivery systems has been instrumental in advancing pharmaceutical technologies.
Collaborations
Kreilgaard has worked alongside talented colleagues, including Ulla Hoeck and Helle Kristensen. Their collaborative efforts have fostered innovation and enhanced the development of effective pharmaceutical solutions.
Conclusion
Bo Kreilgaard's contributions to transdermal drug delivery highlight his role as a key innovator in the pharmaceutical industry. His patent for administering dextromethorphan showcases the potential for improved therapeutic outcomes through innovative delivery methods.